Skip to main content
Equibles

Parallel Advisors, LLC

Position in VTVT — vTv Therapeutics Inc.

CIK 1690010 SAN FRANCISCO, CA
Back to VTVT Full portfolio

Position in VTVT

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$1,430
-$77 QoQ
Shares Held
38
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 45 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in VTVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Parallel Advisors, LLC holds $359,928,308 across 168 Biotechnology names. VTVT ranks #120 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CORT
Corcept Therapeutics Inc
 3,962,177 $344,511,290
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 5,389 $2,676,877
3 RCUS
Arcus Biosciences, Inc.
 86,557 $2,668,552
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,063 $662,823
5 KRYS
Krystal Biotech, Inc.
 1,699 $631,467
6 ARGX
Argenx SE
 640 $593,772
7 INCY
Incyte Corp
 4,961 $562,378
8 VKTX
Viking Therapeutics, Inc.
 13,833 $539,625

All Filings in VTVT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,430 38
2026-03-31 $1,507 38
2025-12-31 $1,519 38
2025-09-30 $887 38
2025-06-30 $570 38
2025-03-31 $658 38
2024-12-31 $524 38
2024-09-30 $515 38
2024-06-30 $671 38
2024-03-31 $894 38
2023-12-31 $437 38
2023-09-30 $717 1,500
2023-06-30 $1,110 1,500
2023-03-31 $1,212 1,500
2022-12-31 $994 1,500
2022-09-30 $1,455 1,500
2022-06-30 $1,125 1,500
2022-03-31 $1,083 1,500
2021-12-31 $1,492 1,500
2021-09-30 $2,295 1,500
2021-06-30 $3,420 1,500
2021-03-31 $4,230 1,500
2020-12-31 $2,790 1,500
2020-09-30 $2,655 1,500
2020-06-30 $3,375 1,500